Innovative thiosemicarbazones that induce multi-modal mechanisms to down-regulate estrogen-, progesterone-, androgen- and prolactin-receptors in breast cancer
出版年份 2023 全文链接
标题
Innovative thiosemicarbazones that induce multi-modal mechanisms to down-regulate estrogen-, progesterone-, androgen- and prolactin-receptors in breast cancer
作者
关键词
-
出版物
PHARMACOLOGICAL RESEARCH
Volume 193, Issue -, Pages 106806
出版商
Elsevier BV
发表日期
2023-05-26
DOI
10.1016/j.phrs.2023.106806
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Designing Tailored Thiosemicarbazones with Bespoke Properties: The Styrene Moiety Imparts Potent Activity, Inhibits Heme Center Oxidation, and Results in a Novel “Stealth Zinc(II) Complex”
- (2023) Mahendiran Dharmasivam et al. Journal of Medicinal Chemistry
- Targeting Wnt/tenascin C-mediated cross talk between pancreatic cancer cells and stellate cells via activation of the metastasis suppressor NDRG1
- (2022) Bekesho Geleta et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The thiosemicarbazone, DpC, broadly synergizes with multiple anti-cancer therapeutics and demonstrates temperature- and energy-dependent uptake by tumor cells
- (2022) Mahendiran Dharmasivam et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Breaking the cycle: Targeting of NDRG1 to inhibit bi‐directional oncogenic cross‐talk between pancreatic cancer and stroma
- (2021) Bekesho Geleta et al. FASEB JOURNAL
- Overcoming tamoxifen resistance in oestrogen receptor‐positive breast cancer using the novel thiosemicarbazone anti‐cancer agent, DpC
- (2020) Sundus N. Maqbool et al. BRITISH JOURNAL OF PHARMACOLOGY
- Unique targeting of androgen‐dependent and ‐independent AR signaling in prostate cancer to overcome androgen resistance
- (2020) Syer C. Lim et al. FASEB JOURNAL
- Pharmacological targeting and the diverse functions of the metastasis suppressor, NDRG1, in cancer
- (2019) Kyung Chan Park et al. FREE RADICAL BIOLOGY AND MEDICINE
- Leptin-induced ER-α-positive breast cancer cell viability and migration is mediated by suppressing CCN5-signaling via activating JAK/AKT/STAT-pathway
- (2018) Inamul Haque et al. BMC CANCER
- The Metastasis Suppressor, NDRG1, Attenuates Oncogenic TGF-β and NF-ĸB Signaling to Enhance Membrane E-Cadherin Expression in Pancreatic Cancer Cells
- (2018) Sharleen V Menezes et al. CARCINOGENESIS
- Interplay of the iron-regulated metastasis suppressor NDRG1 with epidermal growth factor receptor (EGFR) and oncogenic signaling
- (2017) Sharleen V. Menezes et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PI3K pathway regulates ER-dependent transcription in breast cancer through the epigenetic regulator KMT2D
- (2017) Eneda Toska et al. SCIENCE
- Zinc(II)–Thiosemicarbazone Complexes Are Localized to the Lysosomal Compartment Where They Transmetallate with Copper Ions to Induce Cytotoxicity
- (2016) Alexandra E. Stacy et al. JOURNAL OF MEDICINAL CHEMISTRY
- Nuclear and extranuclear-initiated estrogen receptor signaling crosstalk and endocrine resistance in breast cancer
- (2016) Eylem Kulkoyluoglu et al. STEROIDS
- Progesterone induces progesterone receptor gene ( PGR ) expression via rapid activation of protein kinase pathways required for cooperative estrogen receptor alpha (ER) and progesterone receptor (PR) genomic action at ER/PR target genes
- (2016) Caroline H. Diep et al. STEROIDS
- Expression of Androgen Receptor in Estrogen Receptor–positive Breast Cancer
- (2016) Anil Agrawal et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Sensitization of estrogen receptor-positive breast cancer cell lines to 4-hydroxytamoxifen by isothiocyanates present in cruciferous plants
- (2015) Anna Pawlik et al. EUROPEAN JOURNAL OF NUTRITION
- The Metastasis Suppressor, N-MYC Downstream-regulated Gene-1 (NDRG1), Down-regulates the ErbB Family of Receptors to Inhibit Downstream Oncogenic Signaling Pathways
- (2015) Zaklina Kovacevic et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The renaissance of polypharmacology in the development of anti-cancer therapeutics: Inhibition of the “Triad of Death” in cancer by Di-2-pyridylketone thiosemicarbazones
- (2015) Patric J. Jansson et al. PHARMACOLOGICAL RESEARCH
- Progesterone receptor-estrogen receptor crosstalk: a novel insight
- (2015) Christoforos Thomas et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- EGFR and NF-κB: partners in cancer
- (2015) Kateryna Shostak et al. TRENDS IN MOLECULAR MEDICINE
- Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
- (2014) Patricia A.J. Muller et al. CANCER CELL
- US Incidence of Breast Cancer Subtypes Defined by Joint Hormone Receptor and HER2 Status
- (2014) Nadia Howlader et al. JNCI-Journal of the National Cancer Institute
- Functional annotation of noncoding sequence variants
- (2014) Graham R S Ritchie et al. NATURE METHODS
- Quantitative Analysis of the Anti-Proliferative Activity of Combinations of Selected Iron-Chelating Agents and Clinically Used Anti-Neoplastic Drugs
- (2014) Eliska Potuckova et al. PLoS One
- MicroRNA-7 Inhibits Multiple Oncogenic Pathways to Suppress HER2Δ16 Mediated Breast Tumorigenesis and Reverse Trastuzumab Resistance
- (2014) Felicia C. Huynh et al. PLoS One
- featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
- (2013) Y. Liao et al. BIOINFORMATICS
- Targeting BCL-2 with the BH3 Mimetic ABT-199 in Estrogen Receptor-Positive Breast Cancer
- (2013) François Vaillant et al. CANCER CELL
- Dysregulated STAT1-SOCS1 control of JAK2 promotes mammary luminal progenitor cell survival and drives ERα+ tumorigenesis
- (2013) S R Chan et al. CELL DEATH AND DIFFERENTIATION
- RETRACTED ARTICLE: Regulation of estrogen receptor signaling in breast carcinogenesis and breast cancer therapy
- (2013) Zhuan Zhou et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Cross-talk between estradiol receptor and EGFR/IGF-IR signaling pathways in estrogen-responsive breast cancers: Focus on the role and impact of proteoglycans
- (2013) Spyros S. Skandalis et al. MATRIX BIOLOGY
- Transcriptional activity of c-Jun is critical for the suppression of AR function
- (2013) Chih-Chao Hsu et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Macrophages stimulate gastric and colorectal cancer invasion through EGFR Y1086, c-Src, Erk1/2 and Akt phosphorylation and smallGTPase activity
- (2013) A P Cardoso et al. ONCOGENE
- The Prolactin Receptor Transactivation Domain Is Associated with Steroid Hormone Receptor Expression and Malignant Progression of Breast Cancer
- (2012) Alyson A. Fiorillo et al. AMERICAN JOURNAL OF PATHOLOGY
- Estrogen receptor beta binds Sp1 and recruits a corepressor complex to the estrogen receptor alpha gene promoter
- (2012) V. Bartella et al. BREAST CANCER RESEARCH AND TREATMENT
- N-myc downstream regulated gene 1 modulates Wnt-β-catenin signalling and pleiotropically suppresses metastasis
- (2012) Wen Liu et al. EMBO Molecular Medicine
- Development of proteasome inhibitors as research tools and cancer drugs
- (2012) Alfred L. Goldberg JOURNAL OF CELL BIOLOGY
- Novel Second-Generation Di-2-Pyridylketone Thiosemicarbazones Show Synergism with Standard Chemotherapeutics and Demonstrate Potent Activity against Lung Cancer Xenografts after Oral and Intravenous Administration in Vivo
- (2012) David B. Lovejoy et al. JOURNAL OF MEDICINAL CHEMISTRY
- Antitumor Activity of Metal-Chelating Compound Dp44mT Is Mediated by Formation of a Redox-Active Copper Complex That Accumulates in Lysosomes
- (2011) D. B. Lovejoy et al. CANCER RESEARCH
- Cellular Iron Depletion Stimulates the JNK and p38 MAPK Signaling Transduction Pathways, Dissociation of ASK1-Thioredoxin, and Activation of ASK1
- (2011) Yu Yu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Interplay between progesterone and prolactin in mammary development and implications for breast cancer
- (2011) Heather J. Lee et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Novel Thiosemicarbazone Iron Chelators Induce Up-Regulation and Phosphorylation of the Metastasis Suppressor N-myc Down-Stream Regulated Gene 1: A New Strategy for the Treatment of Pancreatic Cancer
- (2011) Z. Kovacevic et al. MOLECULAR PHARMACOLOGY
- Macrophage-elicited loss of estrogen receptor-α in breast cancer cells via involvement of MAPK and c-Jun at the ESR1 genomic locus
- (2011) F Stossi et al. ONCOGENE
- Analysis of estrogen receptor isoforms and variants in breast cancer cell lines
- (2011) MAIE AL-BADER et al. Experimental and Therapeutic Medicine
- Issues and updates: evaluating estrogen receptor-α, progesterone receptor and HER2 in breast cancer
- (2010) D Craig Allred MODERN PATHOLOGY
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
- (2009) M. D. Robinson et al. BIOINFORMATICS
- Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways
- (2008) Stephen Safe et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Polyubiquitination of Prolactin Receptor Stimulates Its Internalization, Postinternalization Sorting, and Degradation via the Lysosomal Pathway
- (2008) B. Varghese et al. MOLECULAR AND CELLULAR BIOLOGY
- Tyrosine1248-phosphorylated HER2 expression and HER2 gene amplification in female invasive ductal carcinomas
- (2008) Kiyomi Taniyama et al. Breast Cancer
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now